Najat Daw

Trials

Studies that name Najat Daw as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:38 UTC. Open this list on ClinicalTrials.gov

• Ph1/Ph2
  NCT01590069 · Aerosolized Aldesleukin in Treating Patients With Lung Metastases

  M.D. Anderson Cancer Center · active not recruiting · Metastatic Malignant Neoplasm in the Lung, Metastatic Melanoma, Metastatic Osteosarcoma · principal investigator
• Ph1
  NCT01088763 · Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia

  National Cancer Institute (NCI) · terminated · Childhood Atypical Teratoid/Rhabdoid Tumor, Childhood Central Nervous System Choriocarcinoma, Childhood Central Nervous System Germinoma · principal investigator
• Ph1
  NCT00040781 · Gefitinib in Treating Children With Refractory Solid Tumors

  National Cancer Institute (NCI) · completed · Unspecified Childhood Solid Tumor, Protocol Specific · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 10:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Children's Oncology Group Phase 1 / Pilot Consortium
  U01CA097452 · NCI · NATIONAL CHILDHOOD CANCER FOUNDATION · PI SUSAN M. BLANEY · fiscal years 2002 to 2011
  Named on NCT01088763, NCT00040781